All-trans-retinoic acid and bleeding/thrombosis

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue SUPPL. 1, 2003, Pages 19-21

  Falanga, Anna ^a   Marchetti, Marina ^a   Barbui, Tiziano ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; BLEEDING; BONE MARROW HYPOPLASIA; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; CHROMOSOME 15; CONFERENCE PAPER; CYTOTOXICITY; DISEASE ASSOCIATION; DOWN REGULATION; FIBRINOLYSIS; HOMEOSTASIS; HUMAN; HYPERCOAGULABILITY; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REDUCTION; REMISSION; THROMBOSIS;

ENDOTHELIUM, VASCULAR; HEMORRHAGE; HEMOSTASIS; HUMANS; NEOPLASMS; THROMBOSIS; TREATMENT OUTCOME; TRETINOIN;

EID: 0344497414     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073283     Document Type: Conference Paper

References (22)

1. Barbui T, Finazzi G, Falanga A: The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1998;91:3093-3102.
2. Rodeghiero F, Avvisati G, Castaman G, et al: Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 1990;75:2112-2117.
3. Tallman MS, Kwaan HC: Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 1992;79:543-553.
4. Falanga A, Iacoviello L, Evangelista V, et al: Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia given all-trans-retinoic acid. Blood 1995;86:1072-1081.
5. Fenaux P, Castaigne S, Dombret H, et al: All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 1992;80:2176-2181.
6. Frankel SR, Eardley A, Heller G, et al: All-trans retinoic acid for acute promyelocytic leukemia. Ann Intern Med 1994;120:278-286.
7. Kanamaru A, Takemoto Y, Tanimoto M, et al: The Japan Adult Leukemia Study Group: All-trans retinoic acid for the treatment of newly diagnosed adult acute promyelocytic leukemia. Blood 1995;85:1202-1206.
8. Estey E, Thall P, Pierce S, et al: Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. J Clin Oncol 1997;15:483-490.
9. Fenaux P, Le Deley MC, Castaigne S, et al: Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993;82:3241-3249.
10. Tallman MS, Andersen JW, Schiffer CA, et al: A prospective randomized study of all-trans retinoic acid induction and maintenance therapy for patients with acute promyelocytic leukemia. N Engl J Med 1997;337:1021-1028.
11. Burnett AK, Grimwade D, Solomon E, et al: Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans-retinoic acid: Results of the randomized MRC trial. Blood 1999;93:4131-4143.
12. Fenaux P, Chastang C, Chevret S, et al: A randomized comparison of all trans-retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenace therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-1200.
13. Sanz MA, Martin G, Rayon C, et al: A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia. Blood 1999;94:3015-3021.
14. Mandelli F, Diverio D, Avvisati G, et al., for the GIMEMA and AIEOP groups: Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997;90:1014-1021.
15. de Lacerda JF, do Carmo JA, Guerra ML, et al: Multiple thrombosis in acute promyelocytic leukaemia after tretinoin. Lancet 1993;342:114-115.
16. Runde V, Aul C, Heyll A, Schneider W: All-trans retinoic acid: Not only a differentiating agent but also an inducer of thromboembolic events in patients with M3 leukemia. Blood 1992;79:534-535.
17. Kocak U, Gursel T, Ozturk G, Kantarci S: Thrombosis during all-trans-retinoic acid therapy in a child with acute promyelocytic leukemia and factor VQ 506 mutation. Pediatr Hematol Oncol 2000;17:177-180.
18. Pogliani EM, Rossini F, Casaroli I, et al: Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy. Acta Haematol 1997;97:228-230.
19. Hashimoto S, Koike T, Tatewaki W, et al: Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 1994;8:1113-1115.
20. Escudier SM, Kantarjian HM, Estey EH: Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid. Leuk Lymphoma 1996;20:435-439.
21. Marchetti M, Falanga A, Giovanelli S, et al: All-trans-retinoic acid increases the adhesion to endothelium of the acute promyelocytic leukemia cell line NB4. Br J Haematol 1996;93:360-366.
22. Marchetti M, Vignoli A, Barbui T, Falanga A: Endothelial cell/leukemic cell interaction effect of all-trans retinoic acid on cell/cell adhesion. Thromb Haemost 1999;(suppl August):16a.